About BrightHeart (via AI Agent)

BrightHeart is a healthcare AI company that develops artificial intelligence-driven software designed to enhance prenatal ultrasound screening, with a particular focus on detecting congenital heart defects (CHDs) in fetuses. The company’s B-Right AI Platform integrates seamlessly into existing ultrasound workflows, providing real-time guidance to clinicians and sonographers. This platform aims to facilitate comprehensive and standardized expert-level assessments during routine anatomy scans, improving image completeness, increasing diagnostic confidence, and potentially reducing the need for repeat scans. [6, 7, 8, 10]

The technology leverages AI to analyze fetal heart ultrasound exams, supporting OB-GYNs in the improved detection of congenital defects and transforming care for newborns. [3, 4, 8] BrightHeart’s B-Right Screen offers AI-powered analysis of eight key structural markers to quickly identify or confidently rule out signs of severe CHD, boasting high sensitivity and specificity. [6, 10] The B-Right Views Fetal Heart component provides AI-guidance to confirm critical fetal heart views, which has been shown to reduce incomplete fetal heart scans in clinical practice. [6, 10] The company has received multiple FDA clearances for its AI platform, including for real-time tablet access to its analysis. [3, 8, 9, 12, 17] BrightHeart’s mission is to empower perinatal healthcare professionals with innovative AI solutions to enhance the accuracy and efficiency of ultrasound assessments, ultimately improving patient outcomes. [11]

Focus Areas

artificial intelligence prenatal ultrasound congenital heart defects obstetrics pediatric cardiology medical imaging diagnostic accuracy clinical workflow optimization

Business Intelligence

Key InvestorsSofinnova Partners, Odyssée Venture, GO Capital, Mussallem CHD Alliance, Lift Value, IDAHO HealthTech Club via Side Angels, Laurent Salomon, Sacha Loiseau, John Gridley
PartnershipsMount Sinai Hospital, GE HealthCare
Acquisitionsunknown
TechnologyCloud-based AI platform, DICOM router installation, cart-side tablet integration, leverages Meta's DINOv2 model
FDA Clearances5 (as of 2025) cleared products (estimated)

What Physicians Need to Know

Specialization: Prenatal Ultrasound & Congenital Heart Defects
BrightHeart specializes in AI-powered analysis of prenatal ultrasound images to detect signs of severe congenital heart defects (CHDs). Their B-Right AI Platform aims to improve the detection rate of CHDs, which are often missed in routine prenatal ultrasounds.
Key Differentiator: Diagnostic Accuracy
The B-Right AI Platform has demonstrated high diagnostic accuracy, with 96% detection of major CHDs, an 88% reduction in false-positive errors, and a 70% reduction in false-negative errors. Studies have shown 98.7% sensitivity for detecting severe CHD indicators and 97.7% specificity in confirming normality among conclusive cases.
Key Differentiator: Clinical Workflow Optimization
BrightHeart's AI-driven protocol completion tracking ensures exam completeness and automates the detection of standard fetal heart views, leading to a 47% reduction in incomplete fetal heart scans and 18% faster reading times.
Technology Stack
BrightHeart's AI software leverages advanced neural networks and was developed with over 50,000 fetal ultrasound examinations from 46+ centers across various regions. They utilize Meta's open-source DINOv2 model for deeper image understanding and accurate video classification.
Regulatory & Integration
BrightHeart's B-Right AI Platform is FDA-cleared and has received CE Mark for commercialization in the European Union. It is designed for seamless integration into existing ultrasound workflows as a plug-and-play solution, compatible with major ultrasound manufacturers and existing reporting solutions.
Physician Tip

BrightHeart's AI platform provides real-time decision support during prenatal ultrasound exams, helping clinicians and sonographers ensure comprehensive and standardized fetal heart assessments. It can improve confidence in identifying both abnormalities and normal findings, reduce the need for repeat scans, and facilitate earlier triage of high-risk cases. The technology is designed to support clinicians without disrupting existing workflows, making expert-level diagnostics more accessible, especially in busy or resource-limited settings.

The B-Right AI Platform integrates seamlessly into existing ultrasound workflows and is compatible with major ultrasound manufacturers and reporting solutions. It offers automatic display on a cart-side tablet during scans for real-time feedback. BrightHeart has also collaborated with GE HealthCare, making its B-Right AI Platform available through GE HealthCare's Volusonu2122 Solution Store. The device outputs are formatted as DICOM files, compatible with any DICOM viewer.

Products by BrightHeart (via AI Agent)

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

BrightHeart (via AI Agent) appears to be a relatively new or niche company, as comprehensive reviews across major platforms like G2, Glassdoor, and Capterra are not readily available. Information regarding specific product reviews or detailed employer feedback is limited, making it challenging to form a robust opinion based on public data from the requested sources.

Overall: Mixed

Strengths

  • Information not readily available from specified sources.
  • Potential for innovation in AI healthcare solutions (inferred from name).
  • Focus on healthcare technology (inferred from name).

Limitations

  • Lack of readily available reviews on G2, Glassdoor, Capterra, and Reddit.
  • Limited public information regarding product features and performance.
  • Scarcity of employer reviews makes assessing company culture difficult.
  • Difficulty in gauging user satisfaction or common pain points due to lack of data.

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Reviewers (general search)

Last updated: 2026-07-31

Videos

News, demos, and interviews about BrightHeart (via AI Agent).

Loading videos...

Videos load interactively. If none appear, search YouTube for BrightHeart (via AI Agent) →

View all on YouTube

Press & Coverage

Medical Device Network
BrightHeart raises u20ac11m to drive AI heart defect detection platform adoption
BrightHeart secured u20ac11 million in Series A funding to advance the commercialization of its AI-based prenatal congenital heart defect (CHD) screening platform, B-Right, which received FDA clearance in November 2024.
2026-01
AuntMinnie
BrightHeart closes on $12.8M funding round - AuntMinnie
BrightHeart, a company developing AI tools for prenatal ultrasound, completed an u20ac11 million ($12.8 million) Series A financing round to support U.S. commercialization, European expansion, and product innovation for its B-Right AI platform.
2026-01
Business Wire
BrightHeart Announces CE Mark and European Launch of its AI Platform for Prenatal Ultrasound - Business Wire
BrightHeart announced it received the CE Mark for its AI platform for prenatal ultrasound, enabling its commercialization across the EU, following its Series A funding and FDA clearances.
2026-06
Medical Economics
BrightHeart gains FDA Clearance for real-time AI analysis tool in fetal heart screenings
BrightHeart received FDA 510(k) clearance for an updated version of its platform, allowing real-time AI-driven analysis via a cart-side tablet during fetal ultrasound exams to detect congenital heart defects.
2025-05
Sofinnova Partners
BrightHeart gets third FDA clearance for B-Right Views AI - Sofinnova Partners
BrightHeart announced its third FDA 510(k) clearance for B-Right Views, an AI-powered tool that automatically detects standard views for second and third-trimester fetal heart ultrasound evaluations.
2025-05
BrightHeart Press
BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations
BrightHeart received FDA 510(k) clearance for its initial AI software designed to enhance prenatal ultrasound evaluations of the fetal heart, marking a significant advancement in prenatal care.
2025-11
FirstWord HealthTech
BrightHeart's AI software boosts prenatal heart defect detection by over 15%: study
Two studies presented at the SMFM 2025 Pregnancy Meeting showed BrightHeart's FDA-cleared AI software improved congenital heart defect detection rates by 15.3% sensitivity and reduced reading time by 18% among specialists.
2025-01
The French Tech Journal
Prenatal Ultrasound, Reinvented: How BrightHeart AI Catches over 95% of Deadly Fetal Heart Defects Before Birth - The French Tech Journal
BrightHeart, a French startup, is redefining prenatal care by using AI to improve the detection of congenital heart defects, with its newly FDA-cleared B-Right Views device providing automated confirmation of recommended views during fetal heart ultrasound exams.
2026-01

Frequently Asked Questions

BrightHeart leverages advanced AI algorithms, including machine learning and deep learning, to analyze prenatal ultrasound images. These AI models are trained on vast datasets of fetal cardiac scans to identify subtle markers and patterns indicative of congenital heart defects, aiming to enhance diagnostic accuracy and provide earlier detection.
BrightHeart's AI solution is designed for seamless integration with existing medical imaging systems and PACS. It provides an automated analysis layer that can flag potential anomalies for physician review, aiming to reduce manual screening time, prioritize high-risk cases, and optimize the overall diagnostic workflow in both obstetrics and pediatric cardiology.
BrightHeart's technology has undergone rigorous validation studies to demonstrate its diagnostic accuracy. These studies compare its performance against traditional expert interpretation of prenatal ultrasounds, showing improved sensitivity and specificity in identifying various congenital heart defects.
BrightHeart is committed to adhering to the highest regulatory standards. Our AI diagnostic tools have received necessary regulatory approvals, such as FDA clearance in the United States and CE mark in Europe, ensuring their safety, efficacy, and compliance with medical device regulations.
BrightHeart offers flexible pricing models tailored to the needs of individual healthcare systems, including subscription-based services. We provide comprehensive technical support, including implementation, training, and ongoing maintenance. We are actively seeking partnerships with healthcare providers and research institutions to further advance and integrate our technology.
BrightHeart prioritizes data privacy and security by implementing robust encryption protocols, anonymization techniques, and strict access controls. Our systems are designed to comply with HIPAA, GDPR, and other relevant data protection regulations, ensuring the confidentiality and integrity of all patient medical imaging data.
BrightHeart is dedicated to continuous innovation in the field of AI-powered prenatal diagnostics. Our long-term vision includes expanding our AI capabilities to detect a broader range of fetal anomalies and integrating with more comprehensive maternal-fetal health platforms. We are a well-funded company with a strong leadership team, ensuring stability and sustained market presence.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.